GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » Total Current Liabilities

Kimia Biosciences (BOM:530313) Total Current Liabilities : ₹0.00 Mil (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Kimia Biosciences Total Current Liabilities?

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Kimia Biosciences's total current liabilities for the quarter that ended in . 20 was ₹0.00

Kimia Biosciences Total Current Liabilities Historical Data

The historical data trend for Kimia Biosciences's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kimia Biosciences Total Current Liabilities Chart

Kimia Biosciences Annual Data
Trend
Total Current Liabilities

Kimia Biosciences Semi-Annual Data
Total Current Liabilities

Kimia Biosciences Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Kimia Biosciences's Total Current Liabilities for the fiscal year that ended in . 20 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=+
+Other Current Liabilities+Current Deferred Liabilities
=+
=0.00

Kimia Biosciences's Total Current Liabilities for the quarter that ended in . 20 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=+
+Other Current Liabilities+Current Deferred Liabilities
=+
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Kimia Biosciences Total Current Liabilities Related Terms

Thank you for viewing the detailed overview of Kimia Biosciences's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Kimia Biosciences (BOM:530313) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » Total Current Liabilities
Comparable Companies
BOM:531739 BOM:532384 BOM:532989 BOM:540686 BOM:532637 BOM:531173 BOM:531726 BOM:532878 BOM:524518 BOM:537536 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034
Website
https://www.kimiabiosciences.com
Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Deflazacort, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.

Kimia Biosciences (BOM:530313) Headlines

No Headlines